Review



recombinant human il 17  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 93

    Structured Review

    R&D Systems recombinant human il 17
    Recombinant Human Il 17, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 55 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il-17/Recombinant+Human+IL-17A+(Human+Cell-expressed)+Protein/10__17161_slash_sjm__v2i4__24358-34-2-10
    Average 93 stars, based on 55 article reviews
    recombinant human il 17 - by Bioz Stars, 2026-09
    93/100 stars

    Images

    Related Articles

    Recombinant:

    Article Title: Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
    Article Snippet: The proinflammatory cytokine interleukin-17 (IL-17) is important for the immune response to pathogens and also contributes to the pathogenesis of various inflammatory diseases.. To avoid persistent inflammation, signaling by the IL-17 receptor (IL-17R), which involves the adaptor protein Act1, must be tightly controlled.. Here, we report that persistent stimulation of HeLa cells with IL-17 resulted in degradation of Act1 and desensitization of IL-17R signaling.

    Article Title: Lipocalin-2 resistance of Salmonella enterica serotype Typhimurium confers an advantage during life in the inflamed intestine
    Article Snippet: Stimulation with cytokines Recombinant human IL-17, IL-22 and IFN-γ were obtained from R&D systems and utilized at the following final concentrations: IL-17, 100 ng/ml; IL-22, 100 ng/ml; IFN-γ, 40 ng/ml.

    Article Title: Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis.
    Article Snippet: Orna Nadiv a, Yiftah Beer b, Michael Goldberg a,∗, Gabriel Agar b, Michael Loos c, Yitzhak Katz a,d a Allergy and Immunology Institute, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel b Orthopedic Department, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel c Istitute of Medical Microbiology and Hygiene, Johannes Gutenburg University, Mainz, Germany d Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Israel

    Article Title: Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
    Article Snippet: HRPTEpiCs were stimulated with various doses of recombinant human IL-17 (rhIL-17, R&D Systems, Inc. Minneapolis, MN)(10, 50, 100 ng/ml) for 72 h. Supernatants were harvested and stored at –80°C until analysis.

    Article Title: Increased urinary excretion of interleukin-17 in nephrotic patients.
    Article Snippet: Background/Aim: Interleukin (IL)-17 is a newly discovered cytokine that is secreted by activated memory CD4+ T cells and modulated the early stage of immune response.. To elucidate the pathophysiology of minimal-change nephrotic syndrome (MCNS), we focused on IL-17, which is one of the key factors in regulating an inflammatory response, and thus determined the daily excretion of IL-17 in urine.. Methods: For this purpose, excretion levels of IL-17 were measured in the urine of patients with MCNS during relapse and remission using a highly sensitive sandwich enzyme-linked immunosorbent assay.

    Staining:

    Article Title: Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
    Article Snippet: The proinflammatory cytokine interleukin-17 (IL-17) is important for the immune response to pathogens and also contributes to the pathogenesis of various inflammatory diseases.. To avoid persistent inflammation, signaling by the IL-17 receptor (IL-17R), which involves the adaptor protein Act1, must be tightly controlled.. Here, we report that persistent stimulation of HeLa cells with IL-17 resulted in degradation of Act1 and desensitization of IL-17R signaling.

    Article Title: Lipocalin-2 resistance of Salmonella enterica serotype Typhimurium confers an advantage during life in the inflamed intestine
    Article Snippet: Stimulation with cytokines Recombinant human IL-17, IL-22 and IFN-γ were obtained from R&D systems and utilized at the following final concentrations: IL-17, 100 ng/ml; IL-22, 100 ng/ml; IFN-γ, 40 ng/ml.

    Article Title: Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis.
    Article Snippet: Orna Nadiv a, Yiftah Beer b, Michael Goldberg a,∗, Gabriel Agar b, Michael Loos c, Yitzhak Katz a,d a Allergy and Immunology Institute, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel b Orthopedic Department, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel c Istitute of Medical Microbiology and Hygiene, Johannes Gutenburg University, Mainz, Germany d Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Israel

    Article Title: Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
    Article Snippet: HRPTEpiCs were stimulated with various doses of recombinant human IL-17 (rhIL-17, R&D Systems, Inc. Minneapolis, MN)(10, 50, 100 ng/ml) for 72 h. Supernatants were harvested and stored at –80°C until analysis.

    Article Title: Increased urinary excretion of interleukin-17 in nephrotic patients.
    Article Snippet: Background/Aim: Interleukin (IL)-17 is a newly discovered cytokine that is secreted by activated memory CD4+ T cells and modulated the early stage of immune response.. To elucidate the pathophysiology of minimal-change nephrotic syndrome (MCNS), we focused on IL-17, which is one of the key factors in regulating an inflammatory response, and thus determined the daily excretion of IL-17 in urine.. Methods: For this purpose, excretion levels of IL-17 were measured in the urine of patients with MCNS during relapse and remission using a highly sensitive sandwich enzyme-linked immunosorbent assay.

    Comparison:

    Article Title: Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
    Article Snippet: The proinflammatory cytokine interleukin-17 (IL-17) is important for the immune response to pathogens and also contributes to the pathogenesis of various inflammatory diseases.. To avoid persistent inflammation, signaling by the IL-17 receptor (IL-17R), which involves the adaptor protein Act1, must be tightly controlled.. Here, we report that persistent stimulation of HeLa cells with IL-17 resulted in degradation of Act1 and desensitization of IL-17R signaling.

    Article Title: Lipocalin-2 resistance of Salmonella enterica serotype Typhimurium confers an advantage during life in the inflamed intestine
    Article Snippet: Stimulation with cytokines Recombinant human IL-17, IL-22 and IFN-γ were obtained from R&D systems and utilized at the following final concentrations: IL-17, 100 ng/ml; IL-22, 100 ng/ml; IFN-γ, 40 ng/ml.

    Article Title: Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis.
    Article Snippet: Orna Nadiv a, Yiftah Beer b, Michael Goldberg a,∗, Gabriel Agar b, Michael Loos c, Yitzhak Katz a,d a Allergy and Immunology Institute, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel b Orthopedic Department, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel c Istitute of Medical Microbiology and Hygiene, Johannes Gutenburg University, Mainz, Germany d Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Israel

    Article Title: Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
    Article Snippet: HRPTEpiCs were stimulated with various doses of recombinant human IL-17 (rhIL-17, R&D Systems, Inc. Minneapolis, MN)(10, 50, 100 ng/ml) for 72 h. Supernatants were harvested and stored at –80°C until analysis.

    Article Title: Increased urinary excretion of interleukin-17 in nephrotic patients.
    Article Snippet: Background/Aim: Interleukin (IL)-17 is a newly discovered cytokine that is secreted by activated memory CD4+ T cells and modulated the early stage of immune response.. To elucidate the pathophysiology of minimal-change nephrotic syndrome (MCNS), we focused on IL-17, which is one of the key factors in regulating an inflammatory response, and thus determined the daily excretion of IL-17 in urine.. Methods: For this purpose, excretion levels of IL-17 were measured in the urine of patients with MCNS during relapse and remission using a highly sensitive sandwich enzyme-linked immunosorbent assay.

    Flow Cytometry:

    Article Title: Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
    Article Snippet: The proinflammatory cytokine interleukin-17 (IL-17) is important for the immune response to pathogens and also contributes to the pathogenesis of various inflammatory diseases.. To avoid persistent inflammation, signaling by the IL-17 receptor (IL-17R), which involves the adaptor protein Act1, must be tightly controlled.. Here, we report that persistent stimulation of HeLa cells with IL-17 resulted in degradation of Act1 and desensitization of IL-17R signaling.

    Article Title: Lipocalin-2 resistance of Salmonella enterica serotype Typhimurium confers an advantage during life in the inflamed intestine
    Article Snippet: Stimulation with cytokines Recombinant human IL-17, IL-22 and IFN-γ were obtained from R&D systems and utilized at the following final concentrations: IL-17, 100 ng/ml; IL-22, 100 ng/ml; IFN-γ, 40 ng/ml.

    Article Title: Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis.
    Article Snippet: Orna Nadiv a, Yiftah Beer b, Michael Goldberg a,∗, Gabriel Agar b, Michael Loos c, Yitzhak Katz a,d a Allergy and Immunology Institute, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel b Orthopedic Department, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel c Istitute of Medical Microbiology and Hygiene, Johannes Gutenburg University, Mainz, Germany d Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Israel

    Article Title: Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
    Article Snippet: HRPTEpiCs were stimulated with various doses of recombinant human IL-17 (rhIL-17, R&D Systems, Inc. Minneapolis, MN)(10, 50, 100 ng/ml) for 72 h. Supernatants were harvested and stored at –80°C until analysis.

    Article Title: Increased urinary excretion of interleukin-17 in nephrotic patients.
    Article Snippet: Background/Aim: Interleukin (IL)-17 is a newly discovered cytokine that is secreted by activated memory CD4+ T cells and modulated the early stage of immune response.. To elucidate the pathophysiology of minimal-change nephrotic syndrome (MCNS), we focused on IL-17, which is one of the key factors in regulating an inflammatory response, and thus determined the daily excretion of IL-17 in urine.. Methods: For this purpose, excretion levels of IL-17 were measured in the urine of patients with MCNS during relapse and remission using a highly sensitive sandwich enzyme-linked immunosorbent assay.

    Expressing:

    Article Title: Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
    Article Snippet: The proinflammatory cytokine interleukin-17 (IL-17) is important for the immune response to pathogens and also contributes to the pathogenesis of various inflammatory diseases.. To avoid persistent inflammation, signaling by the IL-17 receptor (IL-17R), which involves the adaptor protein Act1, must be tightly controlled.. Here, we report that persistent stimulation of HeLa cells with IL-17 resulted in degradation of Act1 and desensitization of IL-17R signaling.

    Article Title: Lipocalin-2 resistance of Salmonella enterica serotype Typhimurium confers an advantage during life in the inflamed intestine
    Article Snippet: Stimulation with cytokines Recombinant human IL-17, IL-22 and IFN-γ were obtained from R&D systems and utilized at the following final concentrations: IL-17, 100 ng/ml; IL-22, 100 ng/ml; IFN-γ, 40 ng/ml.

    Article Title: Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis.
    Article Snippet: Orna Nadiv a, Yiftah Beer b, Michael Goldberg a,∗, Gabriel Agar b, Michael Loos c, Yitzhak Katz a,d a Allergy and Immunology Institute, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel b Orthopedic Department, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel c Istitute of Medical Microbiology and Hygiene, Johannes Gutenburg University, Mainz, Germany d Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Israel

    Article Title: Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
    Article Snippet: HRPTEpiCs were stimulated with various doses of recombinant human IL-17 (rhIL-17, R&D Systems, Inc. Minneapolis, MN)(10, 50, 100 ng/ml) for 72 h. Supernatants were harvested and stored at –80°C until analysis.

    Article Title: Increased urinary excretion of interleukin-17 in nephrotic patients.
    Article Snippet: Background/Aim: Interleukin (IL)-17 is a newly discovered cytokine that is secreted by activated memory CD4+ T cells and modulated the early stage of immune response.. To elucidate the pathophysiology of minimal-change nephrotic syndrome (MCNS), we focused on IL-17, which is one of the key factors in regulating an inflammatory response, and thus determined the daily excretion of IL-17 in urine.. Methods: For this purpose, excretion levels of IL-17 were measured in the urine of patients with MCNS during relapse and remission using a highly sensitive sandwich enzyme-linked immunosorbent assay.

    Real-time Polymerase Chain Reaction:

    Article Title: Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
    Article Snippet: The proinflammatory cytokine interleukin-17 (IL-17) is important for the immune response to pathogens and also contributes to the pathogenesis of various inflammatory diseases.. To avoid persistent inflammation, signaling by the IL-17 receptor (IL-17R), which involves the adaptor protein Act1, must be tightly controlled.. Here, we report that persistent stimulation of HeLa cells with IL-17 resulted in degradation of Act1 and desensitization of IL-17R signaling.

    Article Title: Lipocalin-2 resistance of Salmonella enterica serotype Typhimurium confers an advantage during life in the inflamed intestine
    Article Snippet: Stimulation with cytokines Recombinant human IL-17, IL-22 and IFN-γ were obtained from R&D systems and utilized at the following final concentrations: IL-17, 100 ng/ml; IL-22, 100 ng/ml; IFN-γ, 40 ng/ml.

    Article Title: Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis.
    Article Snippet: Orna Nadiv a, Yiftah Beer b, Michael Goldberg a,∗, Gabriel Agar b, Michael Loos c, Yitzhak Katz a,d a Allergy and Immunology Institute, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel b Orthopedic Department, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel c Istitute of Medical Microbiology and Hygiene, Johannes Gutenburg University, Mainz, Germany d Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Israel

    Article Title: Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
    Article Snippet: HRPTEpiCs were stimulated with various doses of recombinant human IL-17 (rhIL-17, R&D Systems, Inc. Minneapolis, MN)(10, 50, 100 ng/ml) for 72 h. Supernatants were harvested and stored at –80°C until analysis.

    Article Title: Increased urinary excretion of interleukin-17 in nephrotic patients.
    Article Snippet: Background/Aim: Interleukin (IL)-17 is a newly discovered cytokine that is secreted by activated memory CD4+ T cells and modulated the early stage of immune response.. To elucidate the pathophysiology of minimal-change nephrotic syndrome (MCNS), we focused on IL-17, which is one of the key factors in regulating an inflammatory response, and thus determined the daily excretion of IL-17 in urine.. Methods: For this purpose, excretion levels of IL-17 were measured in the urine of patients with MCNS during relapse and remission using a highly sensitive sandwich enzyme-linked immunosorbent assay.

    Enzyme-linked Immunosorbent Assay:

    Article Title: Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
    Article Snippet: The proinflammatory cytokine interleukin-17 (IL-17) is important for the immune response to pathogens and also contributes to the pathogenesis of various inflammatory diseases.. To avoid persistent inflammation, signaling by the IL-17 receptor (IL-17R), which involves the adaptor protein Act1, must be tightly controlled.. Here, we report that persistent stimulation of HeLa cells with IL-17 resulted in degradation of Act1 and desensitization of IL-17R signaling.

    Article Title: Lipocalin-2 resistance of Salmonella enterica serotype Typhimurium confers an advantage during life in the inflamed intestine
    Article Snippet: Stimulation with cytokines Recombinant human IL-17, IL-22 and IFN-γ were obtained from R&D systems and utilized at the following final concentrations: IL-17, 100 ng/ml; IL-22, 100 ng/ml; IFN-γ, 40 ng/ml.

    Article Title: Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis.
    Article Snippet: Orna Nadiv a, Yiftah Beer b, Michael Goldberg a,∗, Gabriel Agar b, Michael Loos c, Yitzhak Katz a,d a Allergy and Immunology Institute, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel b Orthopedic Department, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel c Istitute of Medical Microbiology and Hygiene, Johannes Gutenburg University, Mainz, Germany d Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Israel

    Article Title: Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
    Article Snippet: HRPTEpiCs were stimulated with various doses of recombinant human IL-17 (rhIL-17, R&D Systems, Inc. Minneapolis, MN)(10, 50, 100 ng/ml) for 72 h. Supernatants were harvested and stored at –80°C until analysis.

    Article Title: Increased urinary excretion of interleukin-17 in nephrotic patients.
    Article Snippet: Background/Aim: Interleukin (IL)-17 is a newly discovered cytokine that is secreted by activated memory CD4+ T cells and modulated the early stage of immune response.. To elucidate the pathophysiology of minimal-change nephrotic syndrome (MCNS), we focused on IL-17, which is one of the key factors in regulating an inflammatory response, and thus determined the daily excretion of IL-17 in urine.. Methods: For this purpose, excretion levels of IL-17 were measured in the urine of patients with MCNS during relapse and remission using a highly sensitive sandwich enzyme-linked immunosorbent assay.

    Cell Culture:

    Article Title: Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
    Article Snippet: The proinflammatory cytokine interleukin-17 (IL-17) is important for the immune response to pathogens and also contributes to the pathogenesis of various inflammatory diseases.. To avoid persistent inflammation, signaling by the IL-17 receptor (IL-17R), which involves the adaptor protein Act1, must be tightly controlled.. Here, we report that persistent stimulation of HeLa cells with IL-17 resulted in degradation of Act1 and desensitization of IL-17R signaling.

    Article Title: Lipocalin-2 resistance of Salmonella enterica serotype Typhimurium confers an advantage during life in the inflamed intestine
    Article Snippet: Stimulation with cytokines Recombinant human IL-17, IL-22 and IFN-γ were obtained from R&D systems and utilized at the following final concentrations: IL-17, 100 ng/ml; IL-22, 100 ng/ml; IFN-γ, 40 ng/ml.

    Article Title: Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis.
    Article Snippet: Orna Nadiv a, Yiftah Beer b, Michael Goldberg a,∗, Gabriel Agar b, Michael Loos c, Yitzhak Katz a,d a Allergy and Immunology Institute, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel b Orthopedic Department, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel c Istitute of Medical Microbiology and Hygiene, Johannes Gutenburg University, Mainz, Germany d Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Israel

    Article Title: Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
    Article Snippet: HRPTEpiCs were stimulated with various doses of recombinant human IL-17 (rhIL-17, R&D Systems, Inc. Minneapolis, MN)(10, 50, 100 ng/ml) for 72 h. Supernatants were harvested and stored at –80°C until analysis.

    Article Title: Increased urinary excretion of interleukin-17 in nephrotic patients.
    Article Snippet: Background/Aim: Interleukin (IL)-17 is a newly discovered cytokine that is secreted by activated memory CD4+ T cells and modulated the early stage of immune response.. To elucidate the pathophysiology of minimal-change nephrotic syndrome (MCNS), we focused on IL-17, which is one of the key factors in regulating an inflammatory response, and thus determined the daily excretion of IL-17 in urine.. Methods: For this purpose, excretion levels of IL-17 were measured in the urine of patients with MCNS during relapse and remission using a highly sensitive sandwich enzyme-linked immunosorbent assay.

    Construct:

    Article Title: Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
    Article Snippet: The proinflammatory cytokine interleukin-17 (IL-17) is important for the immune response to pathogens and also contributes to the pathogenesis of various inflammatory diseases.. To avoid persistent inflammation, signaling by the IL-17 receptor (IL-17R), which involves the adaptor protein Act1, must be tightly controlled.. Here, we report that persistent stimulation of HeLa cells with IL-17 resulted in degradation of Act1 and desensitization of IL-17R signaling.

    Article Title: Lipocalin-2 resistance of Salmonella enterica serotype Typhimurium confers an advantage during life in the inflamed intestine
    Article Snippet: Stimulation with cytokines Recombinant human IL-17, IL-22 and IFN-γ were obtained from R&D systems and utilized at the following final concentrations: IL-17, 100 ng/ml; IL-22, 100 ng/ml; IFN-γ, 40 ng/ml.

    Article Title: Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis.
    Article Snippet: Orna Nadiv a, Yiftah Beer b, Michael Goldberg a,∗, Gabriel Agar b, Michael Loos c, Yitzhak Katz a,d a Allergy and Immunology Institute, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel b Orthopedic Department, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel c Istitute of Medical Microbiology and Hygiene, Johannes Gutenburg University, Mainz, Germany d Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Israel

    Article Title: Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
    Article Snippet: HRPTEpiCs were stimulated with various doses of recombinant human IL-17 (rhIL-17, R&D Systems, Inc. Minneapolis, MN)(10, 50, 100 ng/ml) for 72 h. Supernatants were harvested and stored at –80°C until analysis.

    Article Title: Increased urinary excretion of interleukin-17 in nephrotic patients.
    Article Snippet: Background/Aim: Interleukin (IL)-17 is a newly discovered cytokine that is secreted by activated memory CD4+ T cells and modulated the early stage of immune response.. To elucidate the pathophysiology of minimal-change nephrotic syndrome (MCNS), we focused on IL-17, which is one of the key factors in regulating an inflammatory response, and thus determined the daily excretion of IL-17 in urine.. Methods: For this purpose, excretion levels of IL-17 were measured in the urine of patients with MCNS during relapse and remission using a highly sensitive sandwich enzyme-linked immunosorbent assay.

    Infection:

    Article Title: Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
    Article Snippet: The proinflammatory cytokine interleukin-17 (IL-17) is important for the immune response to pathogens and also contributes to the pathogenesis of various inflammatory diseases.. To avoid persistent inflammation, signaling by the IL-17 receptor (IL-17R), which involves the adaptor protein Act1, must be tightly controlled.. Here, we report that persistent stimulation of HeLa cells with IL-17 resulted in degradation of Act1 and desensitization of IL-17R signaling.

    Article Title: Lipocalin-2 resistance of Salmonella enterica serotype Typhimurium confers an advantage during life in the inflamed intestine
    Article Snippet: Stimulation with cytokines Recombinant human IL-17, IL-22 and IFN-γ were obtained from R&D systems and utilized at the following final concentrations: IL-17, 100 ng/ml; IL-22, 100 ng/ml; IFN-γ, 40 ng/ml.

    Article Title: Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis.
    Article Snippet: Orna Nadiv a, Yiftah Beer b, Michael Goldberg a,∗, Gabriel Agar b, Michael Loos c, Yitzhak Katz a,d a Allergy and Immunology Institute, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel b Orthopedic Department, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel c Istitute of Medical Microbiology and Hygiene, Johannes Gutenburg University, Mainz, Germany d Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Israel

    Article Title: Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
    Article Snippet: HRPTEpiCs were stimulated with various doses of recombinant human IL-17 (rhIL-17, R&D Systems, Inc. Minneapolis, MN)(10, 50, 100 ng/ml) for 72 h. Supernatants were harvested and stored at –80°C until analysis.

    Article Title: Increased urinary excretion of interleukin-17 in nephrotic patients.
    Article Snippet: Background/Aim: Interleukin (IL)-17 is a newly discovered cytokine that is secreted by activated memory CD4+ T cells and modulated the early stage of immune response.. To elucidate the pathophysiology of minimal-change nephrotic syndrome (MCNS), we focused on IL-17, which is one of the key factors in regulating an inflammatory response, and thus determined the daily excretion of IL-17 in urine.. Methods: For this purpose, excretion levels of IL-17 were measured in the urine of patients with MCNS during relapse and remission using a highly sensitive sandwich enzyme-linked immunosorbent assay.

    Standard Deviation:

    Article Title: Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
    Article Snippet: The proinflammatory cytokine interleukin-17 (IL-17) is important for the immune response to pathogens and also contributes to the pathogenesis of various inflammatory diseases.. To avoid persistent inflammation, signaling by the IL-17 receptor (IL-17R), which involves the adaptor protein Act1, must be tightly controlled.. Here, we report that persistent stimulation of HeLa cells with IL-17 resulted in degradation of Act1 and desensitization of IL-17R signaling.

    Article Title: Lipocalin-2 resistance of Salmonella enterica serotype Typhimurium confers an advantage during life in the inflamed intestine
    Article Snippet: Stimulation with cytokines Recombinant human IL-17, IL-22 and IFN-γ were obtained from R&D systems and utilized at the following final concentrations: IL-17, 100 ng/ml; IL-22, 100 ng/ml; IFN-γ, 40 ng/ml.

    Article Title: Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis.
    Article Snippet: Orna Nadiv a, Yiftah Beer b, Michael Goldberg a,∗, Gabriel Agar b, Michael Loos c, Yitzhak Katz a,d a Allergy and Immunology Institute, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel b Orthopedic Department, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel c Istitute of Medical Microbiology and Hygiene, Johannes Gutenburg University, Mainz, Germany d Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Israel

    Article Title: Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
    Article Snippet: HRPTEpiCs were stimulated with various doses of recombinant human IL-17 (rhIL-17, R&D Systems, Inc. Minneapolis, MN)(10, 50, 100 ng/ml) for 72 h. Supernatants were harvested and stored at –80°C until analysis.

    Article Title: Increased urinary excretion of interleukin-17 in nephrotic patients.
    Article Snippet: Background/Aim: Interleukin (IL)-17 is a newly discovered cytokine that is secreted by activated memory CD4+ T cells and modulated the early stage of immune response.. To elucidate the pathophysiology of minimal-change nephrotic syndrome (MCNS), we focused on IL-17, which is one of the key factors in regulating an inflammatory response, and thus determined the daily excretion of IL-17 in urine.. Methods: For this purpose, excretion levels of IL-17 were measured in the urine of patients with MCNS during relapse and remission using a highly sensitive sandwich enzyme-linked immunosorbent assay.

    Mutagenesis:

    Article Title: Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
    Article Snippet: The proinflammatory cytokine interleukin-17 (IL-17) is important for the immune response to pathogens and also contributes to the pathogenesis of various inflammatory diseases.. To avoid persistent inflammation, signaling by the IL-17 receptor (IL-17R), which involves the adaptor protein Act1, must be tightly controlled.. Here, we report that persistent stimulation of HeLa cells with IL-17 resulted in degradation of Act1 and desensitization of IL-17R signaling.

    Article Title: Lipocalin-2 resistance of Salmonella enterica serotype Typhimurium confers an advantage during life in the inflamed intestine
    Article Snippet: Stimulation with cytokines Recombinant human IL-17, IL-22 and IFN-γ were obtained from R&D systems and utilized at the following final concentrations: IL-17, 100 ng/ml; IL-22, 100 ng/ml; IFN-γ, 40 ng/ml.

    Article Title: Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis.
    Article Snippet: Orna Nadiv a, Yiftah Beer b, Michael Goldberg a,∗, Gabriel Agar b, Michael Loos c, Yitzhak Katz a,d a Allergy and Immunology Institute, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel b Orthopedic Department, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel c Istitute of Medical Microbiology and Hygiene, Johannes Gutenburg University, Mainz, Germany d Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Israel

    Article Title: Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
    Article Snippet: HRPTEpiCs were stimulated with various doses of recombinant human IL-17 (rhIL-17, R&D Systems, Inc. Minneapolis, MN)(10, 50, 100 ng/ml) for 72 h. Supernatants were harvested and stored at –80°C until analysis.

    Article Title: Increased urinary excretion of interleukin-17 in nephrotic patients.
    Article Snippet: Background/Aim: Interleukin (IL)-17 is a newly discovered cytokine that is secreted by activated memory CD4+ T cells and modulated the early stage of immune response.. To elucidate the pathophysiology of minimal-change nephrotic syndrome (MCNS), we focused on IL-17, which is one of the key factors in regulating an inflammatory response, and thus determined the daily excretion of IL-17 in urine.. Methods: For this purpose, excretion levels of IL-17 were measured in the urine of patients with MCNS during relapse and remission using a highly sensitive sandwich enzyme-linked immunosorbent assay.

    Bacteria:

    Article Title: Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
    Article Snippet: The proinflammatory cytokine interleukin-17 (IL-17) is important for the immune response to pathogens and also contributes to the pathogenesis of various inflammatory diseases.. To avoid persistent inflammation, signaling by the IL-17 receptor (IL-17R), which involves the adaptor protein Act1, must be tightly controlled.. Here, we report that persistent stimulation of HeLa cells with IL-17 resulted in degradation of Act1 and desensitization of IL-17R signaling.

    Article Title: Lipocalin-2 resistance of Salmonella enterica serotype Typhimurium confers an advantage during life in the inflamed intestine
    Article Snippet: Stimulation with cytokines Recombinant human IL-17, IL-22 and IFN-γ were obtained from R&D systems and utilized at the following final concentrations: IL-17, 100 ng/ml; IL-22, 100 ng/ml; IFN-γ, 40 ng/ml.

    Article Title: Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis.
    Article Snippet: Orna Nadiv a, Yiftah Beer b, Michael Goldberg a,∗, Gabriel Agar b, Michael Loos c, Yitzhak Katz a,d a Allergy and Immunology Institute, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel b Orthopedic Department, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel c Istitute of Medical Microbiology and Hygiene, Johannes Gutenburg University, Mainz, Germany d Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Israel

    Article Title: Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
    Article Snippet: HRPTEpiCs were stimulated with various doses of recombinant human IL-17 (rhIL-17, R&D Systems, Inc. Minneapolis, MN)(10, 50, 100 ng/ml) for 72 h. Supernatants were harvested and stored at –80°C until analysis.

    Article Title: Increased urinary excretion of interleukin-17 in nephrotic patients.
    Article Snippet: Background/Aim: Interleukin (IL)-17 is a newly discovered cytokine that is secreted by activated memory CD4+ T cells and modulated the early stage of immune response.. To elucidate the pathophysiology of minimal-change nephrotic syndrome (MCNS), we focused on IL-17, which is one of the key factors in regulating an inflammatory response, and thus determined the daily excretion of IL-17 in urine.. Methods: For this purpose, excretion levels of IL-17 were measured in the urine of patients with MCNS during relapse and remission using a highly sensitive sandwich enzyme-linked immunosorbent assay.

    Incubation:

    Article Title: Persistent stimulation with interleukin-17 desensitizes cells through SCFβ-TrCP-mediated degradation of Act1.
    Article Snippet: The proinflammatory cytokine interleukin-17 (IL-17) is important for the immune response to pathogens and also contributes to the pathogenesis of various inflammatory diseases.. To avoid persistent inflammation, signaling by the IL-17 receptor (IL-17R), which involves the adaptor protein Act1, must be tightly controlled.. Here, we report that persistent stimulation of HeLa cells with IL-17 resulted in degradation of Act1 and desensitization of IL-17R signaling.

    Article Title: Lipocalin-2 resistance of Salmonella enterica serotype Typhimurium confers an advantage during life in the inflamed intestine
    Article Snippet: Stimulation with cytokines Recombinant human IL-17, IL-22 and IFN-γ were obtained from R&D systems and utilized at the following final concentrations: IL-17, 100 ng/ml; IL-22, 100 ng/ml; IFN-γ, 40 ng/ml.

    Article Title: Decreased induction of IL-1beta in fibroblast-like synoviocytes: a possible regulatory mechanism maintaining joint homeostasis.
    Article Snippet: Orna Nadiv a, Yiftah Beer b, Michael Goldberg a,∗, Gabriel Agar b, Michael Loos c, Yitzhak Katz a,d a Allergy and Immunology Institute, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel b Orthopedic Department, “Assaf-Harofeh” Medical Center, Zerifin 70300, Israel c Istitute of Medical Microbiology and Hygiene, Johannes Gutenburg University, Mainz, Germany d Department of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Israel

    Article Title: Increase of Th17 Cell Phenotype in Kidney Transplant Recipients with Chronic Allograft Dysfunction
    Article Snippet: HRPTEpiCs were stimulated with various doses of recombinant human IL-17 (rhIL-17, R&D Systems, Inc. Minneapolis, MN)(10, 50, 100 ng/ml) for 72 h. Supernatants were harvested and stored at –80°C until analysis.

    Article Title: Increased urinary excretion of interleukin-17 in nephrotic patients.
    Article Snippet: Background/Aim: Interleukin (IL)-17 is a newly discovered cytokine that is secreted by activated memory CD4+ T cells and modulated the early stage of immune response.. To elucidate the pathophysiology of minimal-change nephrotic syndrome (MCNS), we focused on IL-17, which is one of the key factors in regulating an inflammatory response, and thus determined the daily excretion of IL-17 in urine.. Methods: For this purpose, excretion levels of IL-17 were measured in the urine of patients with MCNS during relapse and remission using a highly sensitive sandwich enzyme-linked immunosorbent assay.



    Similar Products

    94
    MedChemExpress recombinant il 17
    Recombinant Il 17, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il-17/IL-17A%2C+Human/pm42340520-75-25-28
    Average 94 stars, based on 1 article reviews
    recombinant il 17 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    93
    Proteintech il 17 group
    Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
    Il 17 Group, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il-17/Animal-free+Recombinant+Human+IL-17/pmc12951635-54-1-9
    Average 93 stars, based on 1 article reviews
    il 17 group - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Proteintech il 17
    Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
    Il 17, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il-17/Animal-free+Recombinant+Human+IL-17/pmc12951635-54-8-9
    Average 93 stars, based on 1 article reviews
    il 17 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Proteintech recombinant human il 17a protein
    Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
    Recombinant Human Il 17a Protein, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il-17/Animal-free+Recombinant+Human+IL-17/pm41418940-69-9-14
    Average 93 stars, based on 1 article reviews
    recombinant human il 17a protein - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Proteintech recombinant human il 17 il 17a protein hz 1113 proteintech
    Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
    Recombinant Human Il 17 Il 17a Protein Hz 1113 Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il-17/Animal-free+Recombinant+Human+IL-17/pmc12575227__DataSheet1-23-16-22
    Average 93 stars, based on 1 article reviews
    recombinant human il 17 il 17a protein hz 1113 proteintech - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant human il 17
    Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
    Recombinant Human Il 17, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il-17/Recombinant+Human+IL-17A+(Human+Cell-expressed)+Protein/10__17161_slash_sjm__v2i4__24358-34-2-10
    Average 93 stars, based on 1 article reviews
    recombinant human il 17 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    97
    R&D Systems recombinant il 17
    Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
    Recombinant Il 17, supplied by R&D Systems, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il-17/Recombinant+Human+TNF-alpha+Protein/pmc12466150-41-15-17
    Average 97 stars, based on 1 article reviews
    recombinant il 17 - by Bioz Stars, 2026-09
    97/100 stars
      Buy from Supplier

    93
    Proteintech recombinant cytokines
    Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
    Recombinant Cytokines, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il-17/Animal-free+Recombinant+Human+IL-17/pm40381746-137-17-27
    Average 93 stars, based on 1 article reviews
    recombinant cytokines - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    90
    PeproTech recombinant human il-17a 200-17 protein
    Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in <t>IL-17–stimulated</t> keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.
    Recombinant Human Il 17a 200 17 Protein, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+human+il-17/ifn+%CE%B3/pmc12184322-70-13-21
    Average 90 stars, based on 1 article reviews
    recombinant human il-17a 200-17 protein - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in IL-17–stimulated keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.

    Journal: Frontiers in Pharmacology

    Article Title: Licoisoflavone B alleviates psoriasis via SCD1-targeted lipid metabolism reprogramming and suppression of Th17/IL-17–mediated inflammation

    doi: 10.3389/fphar.2026.1754729

    Figure Lengend Snippet: Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in IL-17–stimulated keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.

    Article Snippet: The IL-17 group was treated with 100 ng/mL IL-17 (Proteintech; HZ-1113); the Lico B group received 9 μM Lico B (MCE; HY-N3388); the IL-17 + Lico B group was co-treated with IL-17 and Lico B; and the control group was treated with PBS.

    Techniques: Biomarker Discovery, In Vitro, In Vivo, Western Blot, Immunofluorescence, Staining, Flow Cytometry

    Schematic illustration of lico B treatment in psoriasis. Lico B modulates lipid metabolic pathways by suppressing SCD1-dependent metabolic reprogramming and reducing lipid droplet accumulation in keratinocyte, while simultaneously attenuating the TH17/IL-17 axis. Through concurrent regulation of keratinocyte metabolism and inflammatory cytokine production, Lico B ameliorate psoriatic skin pathology.

    Journal: Frontiers in Pharmacology

    Article Title: Licoisoflavone B alleviates psoriasis via SCD1-targeted lipid metabolism reprogramming and suppression of Th17/IL-17–mediated inflammation

    doi: 10.3389/fphar.2026.1754729

    Figure Lengend Snippet: Schematic illustration of lico B treatment in psoriasis. Lico B modulates lipid metabolic pathways by suppressing SCD1-dependent metabolic reprogramming and reducing lipid droplet accumulation in keratinocyte, while simultaneously attenuating the TH17/IL-17 axis. Through concurrent regulation of keratinocyte metabolism and inflammatory cytokine production, Lico B ameliorate psoriatic skin pathology.

    Article Snippet: The IL-17 group was treated with 100 ng/mL IL-17 (Proteintech; HZ-1113); the Lico B group received 9 μM Lico B (MCE; HY-N3388); the IL-17 + Lico B group was co-treated with IL-17 and Lico B; and the control group was treated with PBS.

    Techniques:

    Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in IL-17–stimulated keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.

    Journal: Frontiers in Pharmacology

    Article Title: Licoisoflavone B alleviates psoriasis via SCD1-targeted lipid metabolism reprogramming and suppression of Th17/IL-17–mediated inflammation

    doi: 10.3389/fphar.2026.1754729

    Figure Lengend Snippet: Integrated workflow for target prediction and experimental validation of Lico B in psoriasis. Bioinformatic analyses, including WGCNA module construction, gene–trait correlation analysis, multi-database target intersection (GEO, GeneCards, TTD), molecular docking, and SPR analysis were used to identify candidate targets of Lico B. Subsequent in vitro and in vivo experiments—comprising Western blotting, qPCR, immunofluorescence staining, and flow cytometry in IL-17–stimulated keratinocytes and IMQ-induced psoriatic mice—were conducted to validate the therapeutic mechanisms of Lico B.

    Article Snippet: The IL-17 group was treated with 100 ng/mL IL-17 (Proteintech; HZ-1113); the Lico B group received 9 μM Lico B (MCE; HY-N3388); the IL-17 + Lico B group was co-treated with IL-17 and Lico B; and the control group was treated with PBS.

    Techniques: Biomarker Discovery, In Vitro, In Vivo, Western Blot, Immunofluorescence, Staining, Flow Cytometry

    Schematic illustration of lico B treatment in psoriasis. Lico B modulates lipid metabolic pathways by suppressing SCD1-dependent metabolic reprogramming and reducing lipid droplet accumulation in keratinocyte, while simultaneously attenuating the TH17/IL-17 axis. Through concurrent regulation of keratinocyte metabolism and inflammatory cytokine production, Lico B ameliorate psoriatic skin pathology.

    Journal: Frontiers in Pharmacology

    Article Title: Licoisoflavone B alleviates psoriasis via SCD1-targeted lipid metabolism reprogramming and suppression of Th17/IL-17–mediated inflammation

    doi: 10.3389/fphar.2026.1754729

    Figure Lengend Snippet: Schematic illustration of lico B treatment in psoriasis. Lico B modulates lipid metabolic pathways by suppressing SCD1-dependent metabolic reprogramming and reducing lipid droplet accumulation in keratinocyte, while simultaneously attenuating the TH17/IL-17 axis. Through concurrent regulation of keratinocyte metabolism and inflammatory cytokine production, Lico B ameliorate psoriatic skin pathology.

    Article Snippet: The IL-17 group was treated with 100 ng/mL IL-17 (Proteintech; HZ-1113); the Lico B group received 9 μM Lico B (MCE; HY-N3388); the IL-17 + Lico B group was co-treated with IL-17 and Lico B; and the control group was treated with PBS.

    Techniques: